Teen Vaccine Approvals Increasing, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is observing a rise in the number of vaccines targeted at adolescents, CBER Vaccine Research & Review Director Baylor says. Two vaccines for use in adolescents – Menactra and Boostrix – have been approved so far this year; a third, Adacel, has a user fee date of June 11.
You may also be interested in...
Merck Takes A Shot At A June Approval For HPV Vaccine Gardasil
The firm requests a priority review for the human papillomavirus vaccine’s BLA, submitted Dec. 1.
Merck Takes A Shot At A June Approval For HPV Vaccine Gardasil
The firm requests a priority review for the human papillomavirus vaccine’s BLA, submitted Dec. 1.
Merck HPV Vaccine Gardasil Shows 100% Efficacy In Phase III Primary Analysis
Merck plans to submit a BLA for the cervical cancer vaccine in the fourth quarter.